As long COVID-19 emerged, here’s what researchers at Yale learned about the body’s immune response and mysterious symptoms affecting the brain.
- April 08, 2022Source: The New York Times
Scientists are exploring a theory suggesting that exposure to one respiratory virus helps the body fend off competing pathogens.
- March 24, 2022
The goal of the Public Voices Fellowship, an opportunity for 20 faculty at Yale along with those from other universities to participate in the OpEd Project, is for women and underrepresented faculty to write op-eds that appear in leading publications, including the Los Angeles Times, the Boston Globe, Newsweek, and the Washington Post. But the year-long program does much more than simply expand the voices of those engaged in public debate. It has a lasting impact on the fellows and their careers, says Reina Maruyama, PhD, professor of physics and astronomy and Chair of Women Faculty Forum (WFF).
- March 18, 2022
Pathologists and research scientists from Department of Pathology at Yale School of Medicine will be involved in more than 40 presentations and sessions at the United States and Canadian Academy of Pathology (USCAP) 2022 Annual Meeting in Los Angeles March 19-24.
- February 22, 2022
CASE has elected a total of 35 new members, of whom 15 are from YSM/YSPH and three others are from FAS.
- January 25, 2022
Harry Sanchez, MD, Assistant Professor of Pathology at Yale School of Medicine and Director of Yale Autopsy Services, was recently welcomed to the Cancer Signaling Networks Research Program at Yale Cancer Center.
- January 11, 2022
Discoveries & Impact (January 2022)
- December 17, 2021
Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms? Researchers in the lab of Yale’s Richard Flavell decided to pose this question to a “humanized mice” and revealed that the causes of severe COVID may lie in our own antiviral inflammatory response to the virus, the researchers report Dec. 17 in the journal Nature Biotechnology, https://doi.org/10.1038/s41587-021-01155-4. “Early in the course of disease, a strong immune response is crucial for survival,” Sefik said. “Later in the disease, it can be fatal.” The humanized mice models might also reveal strong clues to the causes and potential treatments of so-called long and severe COVID, the scientists said. The research was done in collaboration with Yale’s Akiko Iwasaki, Craig Wilen, Yuval Kluger, Eric Meffre, and Stephanie Halene.
- December 16, 2021Source: YNHH.org
At Yale New Haven Hospital, a hero is an employee, physician or volunteer who deeply embodies the health system’s values and goes above and beyond to exemplify the Standards of Professional Behavior in their interactions with patients, clients, colleagues and visitors. Now in its 15th year, the YNHH Heroes program recognizes these individuals, who were nominated by their peers.
- December 09, 2021Source: Bloomberg News: Balance of Power
Yale University Immunologist, Dr. Ellen Foxman discusses what we know and don't know about the Omicron variant. She spoke with Bloomberg's Joe Mathieu and Emily Wilkins.